Complications of Intrathecal Drug Delivery

Karina Gritsenko; Veronica Carullo; Timothy R. Deer

doi:10.1007/978-1-4939-2110-2_43

Complications of Intrathecal Drug Delivery

Karina Gritsenko, Veronica Carullo, Timothy R. Deer

Anesthesiology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Intrathecal pumps are an option that allows patients who suffer from moderate-to-severe pain to have an improvement in quality of life, reduction in pain, improvement in systemic side effects, and change in function. They also are an option for patients who are at the end of life to improve alertness, reduce fatigue and nausea, and improve survival in the cancer population. This has been noted to be both clinically beneficial and cost effective, especially in those patients who are expected to survive longer than 6 months. Unfortunately, despite the many positive attributes of these devices, they are not without risks. The complications can be classified as surgical, device related, or drug related. This chapter focuses on the complications of intrathecal drug delivery and options to assess and reduce risks.

Original language	English (US)
Title of host publication	Atlas of Implantable Therapies for Pain Management
Subtitle of host publication	Second Edition
Publisher	Springer New York
Pages	301-312
Number of pages	12
ISBN (Electronic)	9781493921102
ISBN (Print)	9781493921096
DOIs	https://doi.org/10.1007/978-1-4939-2110-2_43
State	Published - Jan 1 2015

Keywords

Complications
Granuloma
Intrathecal Drug Delivery
Overdose
Targeted Drug Delivery
Technique
Withdrawal

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-1-4939-2110-2_43

Cite this

@inbook{0f05baf70a4044c8af57acfeeebb154c,

title = "Complications of Intrathecal Drug Delivery",

abstract = "Intrathecal pumps are an option that allows patients who suffer from moderate-to-severe pain to have an improvement in quality of life, reduction in pain, improvement in systemic side effects, and change in function. They also are an option for patients who are at the end of life to improve alertness, reduce fatigue and nausea, and improve survival in the cancer population. This has been noted to be both clinically beneficial and cost effective, especially in those patients who are expected to survive longer than 6 months. Unfortunately, despite the many positive attributes of these devices, they are not without risks. The complications can be classified as surgical, device related, or drug related. This chapter focuses on the complications of intrathecal drug delivery and options to assess and reduce risks.",

keywords = "Complications, Granuloma, Intrathecal Drug Delivery, Overdose, Targeted Drug Delivery, Technique, Withdrawal",

author = "Karina Gritsenko and Veronica Carullo and Deer, {Timothy R.}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2016.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-2110-2_43",

language = "English (US)",

isbn = "9781493921096",

pages = "301--312",

booktitle = "Atlas of Implantable Therapies for Pain Management",

publisher = "Springer New York",

}

TY - CHAP

T1 - Complications of Intrathecal Drug Delivery

AU - Gritsenko, Karina

AU - Carullo, Veronica

AU - Deer, Timothy R.

N1 - Publisher Copyright: © Springer Science+Business Media New York 2016.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Intrathecal pumps are an option that allows patients who suffer from moderate-to-severe pain to have an improvement in quality of life, reduction in pain, improvement in systemic side effects, and change in function. They also are an option for patients who are at the end of life to improve alertness, reduce fatigue and nausea, and improve survival in the cancer population. This has been noted to be both clinically beneficial and cost effective, especially in those patients who are expected to survive longer than 6 months. Unfortunately, despite the many positive attributes of these devices, they are not without risks. The complications can be classified as surgical, device related, or drug related. This chapter focuses on the complications of intrathecal drug delivery and options to assess and reduce risks.

AB - Intrathecal pumps are an option that allows patients who suffer from moderate-to-severe pain to have an improvement in quality of life, reduction in pain, improvement in systemic side effects, and change in function. They also are an option for patients who are at the end of life to improve alertness, reduce fatigue and nausea, and improve survival in the cancer population. This has been noted to be both clinically beneficial and cost effective, especially in those patients who are expected to survive longer than 6 months. Unfortunately, despite the many positive attributes of these devices, they are not without risks. The complications can be classified as surgical, device related, or drug related. This chapter focuses on the complications of intrathecal drug delivery and options to assess and reduce risks.

KW - Complications

KW - Granuloma

KW - Intrathecal Drug Delivery

KW - Overdose

KW - Targeted Drug Delivery

KW - Technique

KW - Withdrawal

UR - http://www.scopus.com/inward/record.url?scp=85061955020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061955020&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-2110-2_43

DO - 10.1007/978-1-4939-2110-2_43

M3 - Chapter

AN - SCOPUS:85061955020

SN - 9781493921096

SP - 301

EP - 312

BT - Atlas of Implantable Therapies for Pain Management

PB - Springer New York

ER -

Complications of Intrathecal Drug Delivery

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this